Chemcon Speciality Chemicals Ltd
Chemcon Speciality Chemicals Ltd Q2 FY25 Results & Presentation Highlights: Revenue ₹52.6 Cr, EBITDA margin 16.2%
Q2 FY25 investor presentation: what the company reported on revenue, margins and projects.
Based on Chemcon Speciality Chemicals Ltd's Q2 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q2 FY25 Revenue from Operations: Rs 52.6 Crs, down from Rs 75.2 Crs in Q2 FY24 (approx. Q2 FY25 Financials (Page 6 & 8): - EBITDA: Rs.
From Chemcon Speciality Chemicals Ltd's Q2 FY25 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q2 FY25 Revenue from Operations: Rs 52.6 Crs, down from Rs 75.2 Crs in Q2 FY24 (approx. -30% YoY).
- Sales Volume (MT) Q2 FY25: 2,877 MT vs. 2,851 MT in Q2 FY24 (slight increase YoY).
- Revenue Business-wise Q2 FY25: Organic Chemicals 30%, Inorganic Chemicals 68%, Others 2%.
- Revenue Geographic-wise Q2 FY25: Domestic 43%, Export 57%.
- Explicit Outlook:
- Soft performance due to subdued demand in organic chemicals (HMDS, CMIC, Bromobenzene) and volatility in inorganic chemicals.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Chemcon Speciality Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Capacity Expansion involves adding two new organic chemical manufacturing units:
- Proposed P-10 unit expected by Q4 FY25
- Proposed P-11 unit expected by Q1 FY26
- Existing installed capacities:
- Organic Chemicals (HMDS, CMIC, Bromobenzene): 10,800 MTPA
- Inorganic Chemicals (Bromides): 15,000 MTPA
- Capital Work in Progress increased from Rs. 13.6 Cr (Mar-23) to Rs. 42.4 Cr (Mar-24), and further to Rs. 48.3 Cr (Sept-24), indicating ongoing investment in expansion projects.
- The presentation mentions "Capacity Expansion" and "New Products" as growth drivers, aiming for diversified product portfolio and client base.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Chemcon Speciality Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Chemcon Speciality Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹75 Cr, net profit ₹6 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Chemcon Speciality Chemicals Ltd's management said in earlier quarters
- Q3 FY24 earnings call analysis →
- Q4 FY24 earnings call analysis →
- Q1 FY25 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q2 FY24 earnings call →
- Q3 FY23 earnings call →
- Q2 FY23 earnings call →
- Q4 FY22 earnings call →
- Q3 FY22 earnings call →
- Q2 FY22 earnings call →
- Q1 FY22 earnings call →
- Q4 FY21 earnings call →
Others in Chemicals & Petrochemicals this season
- Himadri Speciality Chemical Ltd (Q2 FY25)
1,135.21 Cr, up 13.01% YoY (Page 45) . Key investor presentation takeaways from Himadri Speciality Chemical Ltd's Q2 FY25 investor presentation — and how it ran
- Vidhi Specialty Food Ingredients Ltd (Q2 FY25)
Year-on-Year (Y-o-Y) growth: 13.9% (Page 8) . Key investor presentation takeaways from Vidhi Specialty Food Ingredients Ltd's Q2 FY25 investor presentation — an
- Valiant Organics Ltd (Q2 FY25)
Consolidated: INR 1,602 Mn (down 21.1% YoY from INR 2,031 Mn in Q2-FY24) . Key investor presentation takeaways from Valiant Organics Ltd's Q2 FY25 investor pres
- Excel Industries Ltd (Q2 FY25)
Q2 FY25 standalone revenue from operations: ₹269 crore, up 1.51% QoQ from Q1 FY25 (₹265 crore). Key investor presentation takeaways from Excel Industries Ltd's
Frequently Asked Questions
What were Chemcon Speciality Chemicals Ltd Q2 FY25 results?
Q2 FY25 Revenue from Operations: Rs 52.6 Crs, down from Rs 75.2 Crs in Q2 FY24 (approx. Q2 FY25 Financials (Page 6 & 8): - EBITDA: Rs.
What is Chemcon Speciality Chemicals Ltd share price analysis?
Chemcon Speciality Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 28.1 with a market cap of ₹793 Cr. Investors should review the full earnings analysis for detailed insights.
Is Chemcon Speciality Chemicals Ltd planning capital expenditure?
Capacity Expansion involves adding two new organic chemical manufacturing units: - Proposed P-10 unit expected by Q4 FY25 - Proposed P-11 unit expected by Q1 FY26 - Existing installed capacities: - Organic Chemicals (HMDS, CMIC, Bromobenzene): 10,800 MTPA - Inorganic Chemicals (Bromides): 15,000 MTPA - Capital Work in Progress increased from Rs.
Keep Chemcon Speciality Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.